Skip to search formSkip to main contentSkip to account menu

MCI 9042

Known as: MCI-9042 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

sarpogrelate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Sarpogrelate, a 5-HT2A receptor antagonist in intermittent claudication. A Phase II European study
This was a multinational, multicentre, double-blind Phase II study in Europe to evaluate the efficacy and safety of two dose… 
2003
2003
5-HT(2) receptor-mediated phosphoinositide hydrolysis in bovine ciliary epithelium.
The serotonin 2 (5-HT(2)) receptor antagonists, MCI-9042 (Anplag) and ketanserin, have been shown to lower intraocular pressure… 
2003
2003
Effect of MCI-9042, a 5-HT2 receptor antagonist, on retinal ganglion cell death and retinal ischemia.
1997
1997
Role of serotonin in nephrotoxic serum nephritis in WKY rats.
1996
1996
The effect of a 5HT2 receptor antagonist sarpogrelate (MCI-9042) treatment on platelet function in Buerger's disease.
1995
1995
Role of 5-hydroxytryptamine in platelet thrombus formation and mechanisms of inhibition of thrombus formation by 5-hydroxytryptamine2A antagonists in rabbits.
The role of 5-hydroxytryptamine (5-HT) in platelet thrombus formation and in the mechanisms of inhibition of thrombus formation… 
1992
1992
IMPROVEMENT OF RED BLOOD CElL DEFORMABILITY BY A NEW ANTI-PLAlELET AGENT, MCI-9042
We investigated the effect of a new antiplatelet agent, MCI-9042 «±)-2-(dimethyl­ amino )-1-[[ o-(m-methoxyphenethyl)phenoxy… 
1992
1992
Binding of [3H]Haloperidol to Dopamine D2 Receptors in the Rat Striatum
Abstract— The present study was designed to examine the properties of [3H]haloperidol binding to dopamine D2‐receptors in rat… 
1991
1991
Binding characteristics of [3H]ketanserin for serotonin-2 receptor in the rabbit platelet.
The present study was designed to examine 1) the properties of [3H]ketanserin binding to serotonin-2 (5HT2)-serotonergic… 
1990
1990
Syntheses and platelet aggregation inhibitory and antithrombotic properties of [2-[(omega-aminoalkoxy)phenyl]ethyl]benzenes.
A series of [2-[(omega-aminoalkoxy)phenyl]ethyl]benzene derivatives were synthesized and evaluated for their ability to inhibit… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)